RoslinCT is a Contract Development and Manufacturing Organisation (CDMO) offering process development, technology transfer, GMP manufacture and batch release of cell-based therapies and Advanced Therapy Medicinal Products (ATMPs) for clinical trials in Europe and the US.

RoslinCT provides superior development and manufacturing services, and has a vision to deliver life-changing cell-based products to patients in need. Building success on expert knowledge and progressive partnerships, RoslinCT aims to lead the field in cell and gene therapy manufacturing and to be the global partner of choice. Together with a passion for innovation and a flexible and personalised approach, RoslinCT can support clients at every step of the cell therapy development journey providing a viable route through to commercial manufacture.

Contact RoslinCT
+44(0)131 658 5189
enquiries@roslinct.com
Fiona Bellot: fiona.bellot@roslinct.com
Visit Website